Anemia and diabetes in the absence of nephropathy

被引:101
作者
Craig, KJ
Williams, JD
Riley, SG
Smith, H
Owens, DR
Worthing, D
Cavill, I
Phillips, AO
机构
[1] Cardiff Univ, Coll Med, Inst Nephrol, Cardiff CF14 4XN, S Glam, Wales
[2] Llandough Hosp, Diabet Res Unit, Cardiff, S Glam, Wales
[3] Univ Wales Hosp, Dept Haematol, Cardiff CF4 4XW, S Glam, Wales
关键词
D O I
10.2337/diacare.28.5.1118
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - Patients With diabetes commonly have a greater degree of anemia for then level of renal impairment than those presenting with other causes of rental failure. To clarify the contribution and differing roles of diabetes and nephropathy in the development of anemia in diabetic patients, we examined the hematologic and hematinic parameters of diabetic patients without nephropathy. RESEARCH DESIGN AND METHODS - The study group was comprised of 62 patients with type 2 diabetes who had been followed for a median of 7 years. For the study, these patients had additional samples taken during their annual routine blood testing for the measurement of extra parameters, including serum ferritin, serum erythropoietin (Epo) levels, and the percentage of reticulocytes. These measurements Were combined With the routine parameters Hb, hematocrit, HbA(1c), and glomerular filtration rate. RESULTS - In all, 8 of the 45 male patients (17.8%) and 2 01 the 17 female patients (11.8%) were classified as anemic (Hb < 13g/dl and < 11.5g/dI, respectively). Although only a small number of the patients had anemia as defined by normal values, a retrospective analysis of individual patients over Lime revealed a sustained though small decrease in Hb from initial presentation. A statistically significant difference in Epo levels (P = 0.016 by Kruskal-Wallis test) was observed from the group With the lowest (Hb <= 11.5) to that with the highest (Hb >= 14.5) Hb values, with a median Epo value of 37 (interquartile range 24-42) vs. 13 (9-15) IU/l, respectively. In contrast, there was no evidence of an increased reticulocyte response to higher levels of Epo (r = 0. 134 [Pearsons], P = 0.36). Reticulocyle counts ranged from 44 (38-57) to 76.5 (56-83) in the lowest and highest Hb groups, respectively. CONCLUSIONS - Although only a small number of subjects in the group Were overtly anemic, all subjects had an ongoing, small but significant decrease in Hb since presentation. This study of diabetic patients Without nephropathy shows an expected increase in Epo production in response to lowering levels of Hb but Without the expected reticulocyte response.
引用
收藏
页码:1118 / 1123
页数:6
相关论文
共 20 条
[1]   TRENDS IN CARDIOVASCULAR RISK-FACTORS IN AUSTRALIA - RESULTS FROM THE NATIONAL-HEART-FOUNDATIONS RISK FACTOR PREVALENCE STUDY, 1980-1989 [J].
BENNETT, SA ;
MAGNUS, P .
MEDICAL JOURNAL OF AUSTRALIA, 1994, 161 (09) :519-527
[2]   Erythropoietin response to hypoxia in patients with diabetic autonomic neuropathy and non-diabetic chronic renal failure [J].
Bosman, DR ;
Osborne, CA ;
Marsden, JT ;
Macdougall, IC ;
Gardner, WN ;
Watkins, PJ .
DIABETIC MEDICINE, 2002, 19 (01) :65-69
[3]   Anemia with erythropoietin deficiency occurs early in diabetic nephropathy [J].
Bosman, DR ;
Winkler, AS ;
Marsden, JT ;
Macdougall, IC ;
Watkins, PJ .
DIABETES CARE, 2001, 24 (03) :495-499
[4]   Abysmal prognosis of patients with type 2 diabetes entering dialysis [J].
Chantrel, F ;
Enache, I ;
Bouiller, M ;
Kolb, I ;
Kunz, K ;
Petitjean, P ;
Moulin, B ;
Hannedouche, T .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (01) :129-136
[5]   Risk factors for renal replacement therapy in the Early Treatment Diabetic Retinopathy Study (ETDRS), Early Treatment Diabetic Retinopathy Study Report No. 26 [J].
Cusick, M ;
Chew, EY ;
Hoogwerf, B ;
Agrón, E ;
Wu, L ;
Lindley, A ;
Ferris, FL .
KIDNEY INTERNATIONAL, 2004, 66 (03) :1173-1179
[6]   Patterns of renal injury in NIDDM patients with microalbuminuria [J].
Fioretto, P ;
Mauer, M ;
Brocco, E ;
Velussi, M ;
Frigato, F ;
Muollo, B ;
Sambataro, M ;
Abaterusso, C ;
Baggio, B ;
Crepaldi, G ;
Nosadini, R .
DIABETOLOGIA, 1996, 39 (12) :1569-1576
[7]   SAD TRUTH ABOUT HEMODIALYSIS IN DIABETIC NEPHROPATHY [J].
GHAVAMIAN, M ;
KOLFF, WJ ;
GUTCH, CF ;
KOPP, KF .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1972, 222 (11) :1386-+
[8]   Role of cytokines in the response to erythropoietin in hemodialysis patients [J].
Goicoechea, M ;
Martin, J ;
De Sequera, P ;
Quiroga, JA ;
Ortiz, A ;
Carreño, V ;
Caramelo, C .
KIDNEY INTERNATIONAL, 1998, 54 (04) :1337-1343
[9]   Treating anemia early in renal failure patients slows the decline of renal function: A randomized controlled trial [J].
Gouva, C ;
Nikolopoulos, P ;
Ioannidis, JPA ;
Siamopoulos, KC .
KIDNEY INTERNATIONAL, 2004, 66 (02) :753-760
[10]  
Kaysen GA, 2001, J AM SOC NEPHROL, V12, P1549, DOI 10.1681/ASN.V1271549